4.5.2.0: Centrally-acting appetite suppressants

Part of chapter 4 Central Nervous System, section 4.5 Drugs used in the treatment of obesity

High-level prescribing trends for Centrally-acting appetite suppressants (BNF section 4.5.2.0) across Camden Health Improvement Practice for the last five years. You can explore prescribing trends for this section by Sub-ICB Location, or learn more about this site.

View all matching dm+d items.

No prescriptions found.

Do you need help with your analysis? Don't forget to check the FAQ page, and get in touch if you have questions.

Chemicals

Mazindol (0405020N0)
Naltrexone/bupropion (0405020U0)
Rimonabant (0405020T0)
Sibutramine (0405020S0)
Feedback